Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/06/21
End: 11/04/23
Due: 11/04/24
Phase: N/A
Priority: Normal
Start: 08/02/18
End: 02/29/20
Due: 02/28/21
Phase: N/A
Priority: Normal
Start: 06/14/17
End: 08/30/19
Due: 08/30/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| IEIK13 For Neurosurgery | NCT04953949 | 3-D Matrix Europe SAS | user2@example.com | None | 2021-08-06 | 2023-11-04 | 2024-11-04 | - | - | 2025-07-14 |
| Post-Market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Liver Surgery | NCT03600168 | 3-D Matrix Europe SAS | user2@example.com | None | 2018-08-02 | 2020-02-29 | 2021-02-28 | - | - | 2025-07-14 |
| Post-market Clinical Study to Confirm Safety and Performance of PuraStat® for the Management of Bleeding in Vascular Surgery. | NCT03103282 | 3-D Matrix Europe SAS | user2@example.com | None | 2017-06-14 | 2019-08-30 | 2020-08-30 | - | - | 2025-07-14 |